Direct to consumer advertising of drugs in Europe
- PMID: 17855287
- PMCID: PMC1976477
- DOI: 10.1136/bmj.39310.506308.AD
Direct to consumer advertising of drugs in Europe
Abstract
Evidence on its benefits and harms is available but is being ignored
Conflict of interest statement
Competing interests: None declared.
Comment in
-
Direct to consumer advertisement: The world of the market place.BMJ. 2007 Oct 6;335(7622):683-4. doi: 10.1136/bmj.39346.496690.3A. BMJ. 2007. PMID: 17916818 Free PMC article. No abstract available.
References
-
- Committee on the Assessment of the US Drug Safety System. Baciu A, Stratton K, Burke SP, eds. The future of drug safety: promoting and protecting the health of the public Washington, DC: National Academies Press, 2007
-
- Schuchman M. Drug risks and free speech—can Congress ban consumer ads? N Engl J Med 2007;356:2236-9. - PubMed
-
- Ministry of Health. Direct-to-consumer advertising of prescription medicines in New Zealand: consultation document Wellington: MoH, 2006. http://tinyurl.com/kgw3y
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical